Cantor E H, Abraham S, Marcum E A, Spector S
Eur J Pharmacol. 1983 May 20;90(1):75-83. doi: 10.1016/0014-2999(83)90215-7.
The hypotensive action of various antimuscarinic compounds structurally related to atropine was studied in conscious, unanesthetized rats. The alpha-adrenolytic activity of these agents was assessed both in vivo (blockade of norepinephrine-induced pressor response) and in vitro (displacement of [3H]WB-4101 binding). Benztropine, homatropine and hyoscyamine caused hypotension and produced alpha-adrenergic receptor blockade similar to atropine. Other analogues were either inactive (atroscine, scopolamine, tropic acid and tropine) or evoked nonspecific changes in blood pressure and lacked alpha-adrenolytic activity (benactyzine, eucatropine, methylatropine, methylhomatropine and methylscopolamine). Based on these data, we propose the following structure-activity relationship for hypotension and alpha-adrenolytic activity: (a) the tropine moiety is inactive unless it is attached to another group by an ester linkage, (b) chemical modification of the tropine moiety, including quaternization, decreases potency, (c) the d-stereoisomer appears to be more potent than the corresponding 1-form.
在清醒、未麻醉的大鼠中研究了与阿托品结构相关的各种抗毒蕈碱化合物的降压作用。这些药物的α-肾上腺素能阻断活性通过体内(去甲肾上腺素诱导的升压反应的阻断)和体外([3H]WB-4101结合的置换)进行评估。苯海索、后马托品和莨菪碱引起低血压,并产生与阿托品相似的α-肾上腺素能受体阻断作用。其他类似物要么无活性(阿托品、东莨菪碱、托品酸和托品),要么引起血压的非特异性变化且缺乏α-肾上腺素能阻断活性(苯那辛、尤卡托品、甲基阿托品、甲基后马托品和甲基东莨菪碱)。基于这些数据,我们提出了以下关于低血压和α-肾上腺素能阻断活性的构效关系:(a) 托品部分无活性,除非它通过酯键与另一个基团相连;(b) 托品部分的化学修饰,包括季铵化,会降低效力;(c) d-立体异构体似乎比相应的l-型更有效。